Muscular Dystrophy Association Announces Over $5 Million in Research Grants to Advance Neuromuscular Disease Research [Yahoo! Finance]
Ionis Pharmaceuticals, Inc. (IONS)
Last ionis pharmaceuticals, inc. earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ionispharma.com
Company Research
Source: Yahoo! Finance
Some of the researchers and institutions receiving grants include James Dowling, M.D., Ph.D. (The Hospital for Sick Children), Jyoti Jaiswal, Ph.D (Children's Research Institute), Scot Wolfe, Ph.D. (University of Massachusetts Chan Medical School), and Virginia Kimonis, M.D., M.R.C.P. (University of California Irvine), among others. Was this helpful? Yes No What is the goal of the MDA's research funding strategy? The MDA's strategic approach to funding research across a broad array of neuromuscular diseases ensures that findings in one disease area can often accelerate advancements in others, maximizing the potential for breakthroughs that have led to life-changing treatments and care. Was this helpful? Yes No What is the focus of the research grants awarded by the MDA? The grants fund research across a wide spectrum of neuromuscular diseases, such as amyotrophic lateral sclerosis (ALS), Duchenne and Becker muscular dystrophy, spinal muscular atrophy (SMA), facios
Show less
Read more
Impact Snapshot
Event Time:
IONS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IONS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IONS alerts
High impacting Ionis Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
IONS
News
- Are Investors Undervaluing Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) By 30%? [Yahoo! Finance]Yahoo! Finance
- PANTHERx® Rare Selected by Ionis as Specialty Pharmacy for TRYNGOLZA™ (olezarsen) [Yahoo! Finance]Yahoo! Finance
- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $60.00 price target on the stock.MarketBeat
- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its "outperform" rating re-affirmed by analysts at William Blair.MarketBeat
- FDA Approves Ionis Pharmaceuticals' Rare Genetic Disease Therapy to Lower High-Level Of Fat In Blood [Yahoo! Finance]Yahoo! Finance
IONS
Earnings
- 11/6/24 - Beat
IONS
Sec Filings
- 12/26/24 - Form 4
- 12/20/24 - Form 8-K
- 11/14/24 - Form SC
- IONS's page on the SEC website